Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
2125313 | European Journal of Cancer | 2009 | 5 Pages |
Abstract
The previous studies have stressed on the importance of loco-regional control in the management of high-risk neuroblastoma. We searched the Surveillance, Epidemiology and End-Results (SEER) database for patients older than 2 years with metastatic neuroblastoma who were diagnosed from 1998 to 2005. We identified 291 patients (mean age, 4.35 years). The 5-year survival estimate was 53.2% ± 6.4% for patients who had complete resection of their primary tumours (n = 116) and 35.7% ± 4.7% for patients who did not have complete resection (p = 0.003). External-beam radiotherapy did not affect survival (p = 0.79); this finding has to be taken with caution due to the study limitations.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Iyad Sultan, Khalil Ghandour, Usama Al-Jumaily, Sameh Hashem, Carlos Rodriguez-Galindo,